As molecular biology workflows grow more complex, moving from design to experimental decision making requires connected, traceable data for confident scientific choices. However, fragmented tools, siloed workflows, and gaps between molecular design and experimental analytics often slow progress.
In this Teach Me in 10, Dr. Larry Mulcahy, Product Manager of Biologics at Revvity, explains how Signals BioDesign software supports modern design–make–test–decide (DMTD) workflows in biologic drug development. He also shows how a connected environment integrates molecular design with experimental data, accelerates iteration, and enables more confident decisions across teams.
Watch this episode to discover:
- How a connected environment reduces inefficiencies and accelerates R&D decisions
- Why linking biology and chemistry workflows matters for emerging modalities
- How BioDesign supports scientific decision making and integrates plasmid and protein design across biologics
Further resources:
